CN117257885A - 季德胜蛇药物组合物在制备治疗新冠病毒感染所致头痛、咽痛的药物中的用途 - Google Patents
季德胜蛇药物组合物在制备治疗新冠病毒感染所致头痛、咽痛的药物中的用途 Download PDFInfo
- Publication number
- CN117257885A CN117257885A CN202310091833.2A CN202310091833A CN117257885A CN 117257885 A CN117257885 A CN 117257885A CN 202310091833 A CN202310091833 A CN 202310091833A CN 117257885 A CN117257885 A CN 117257885A
- Authority
- CN
- China
- Prior art keywords
- tablets
- coronavirus infection
- new coronavirus
- formulation
- snake
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000001528 Coronaviridae Infections Diseases 0.000 title claims abstract description 33
- 239000003814 drug Substances 0.000 title claims abstract description 27
- 239000000203 mixture Substances 0.000 title claims abstract description 24
- 206010019233 Headaches Diseases 0.000 title claims abstract description 12
- 231100000869 headache Toxicity 0.000 title claims abstract description 12
- 201000010099 disease Diseases 0.000 claims abstract description 15
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 15
- 229940079593 drug Drugs 0.000 claims abstract description 11
- 206010037660 Pyrexia Diseases 0.000 claims abstract description 10
- 206010063659 Aversion Diseases 0.000 claims abstract description 7
- 241000270295 Serpentes Species 0.000 claims abstract description 6
- 206010035664 Pneumonia Diseases 0.000 claims abstract description 5
- 208000027499 body ache Diseases 0.000 claims abstract description 5
- 238000009472 formulation Methods 0.000 claims description 12
- 239000003826 tablet Substances 0.000 claims description 12
- 239000008194 pharmaceutical composition Substances 0.000 claims description 9
- 239000002775 capsule Substances 0.000 claims description 7
- 239000008187 granular material Substances 0.000 claims description 4
- 241000202726 Bupleurum Species 0.000 claims description 3
- 238000009098 adjuvant therapy Methods 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 230000002265 prevention Effects 0.000 claims description 3
- 244000303040 Glycyrrhiza glabra Species 0.000 claims description 2
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims description 2
- 235000006484 Paeonia officinalis Nutrition 0.000 claims description 2
- 244000273928 Zingiber officinale Species 0.000 claims description 2
- 235000006886 Zingiber officinale Nutrition 0.000 claims description 2
- 239000006189 buccal tablet Substances 0.000 claims description 2
- 239000007910 chewable tablet Substances 0.000 claims description 2
- 239000007891 compressed tablet Substances 0.000 claims description 2
- 239000007919 dispersible tablet Substances 0.000 claims description 2
- 239000008298 dragée Substances 0.000 claims description 2
- 239000007938 effervescent tablet Substances 0.000 claims description 2
- 239000002662 enteric coated tablet Substances 0.000 claims description 2
- 239000007941 film coated tablet Substances 0.000 claims description 2
- 235000008397 ginger Nutrition 0.000 claims description 2
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims description 2
- 239000007902 hard capsule Substances 0.000 claims description 2
- 239000007924 injection Substances 0.000 claims description 2
- 238000002347 injection Methods 0.000 claims description 2
- 239000007942 layered tablet Substances 0.000 claims description 2
- 239000008297 liquid dosage form Substances 0.000 claims description 2
- 239000012669 liquid formulation Substances 0.000 claims description 2
- 235000011477 liquorice Nutrition 0.000 claims description 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 2
- 239000006187 pill Substances 0.000 claims description 2
- 239000002994 raw material Substances 0.000 claims description 2
- 239000007901 soft capsule Substances 0.000 claims description 2
- 239000007787 solid Substances 0.000 claims description 2
- 239000000243 solution Substances 0.000 claims description 2
- 239000006190 sub-lingual tablet Substances 0.000 claims description 2
- 239000007940 sugar coated tablet Substances 0.000 claims description 2
- 239000007939 sustained release tablet Substances 0.000 claims description 2
- 239000004480 active ingredient Substances 0.000 claims 2
- 241001106477 Paeoniaceae Species 0.000 claims 1
- 208000006083 Hypokinesia Diseases 0.000 abstract description 3
- 238000011160 research Methods 0.000 abstract description 2
- 208000002193 Pain Diseases 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 208000004078 Snake Bites Diseases 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 230000003467 diminishing effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 230000006996 mental state Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 1
- 244000248416 Fagopyrum cymosum Species 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 208000006877 Insect Bites and Stings Diseases 0.000 description 1
- 206010028748 Nasal obstruction Diseases 0.000 description 1
- 244000170916 Paeonia officinalis Species 0.000 description 1
- 206010035737 Pneumonia viral Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 229940046011 buccal tablet Drugs 0.000 description 1
- 229940068682 chewable tablet Drugs 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 229940023488 pill Drugs 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 229940098466 sublingual tablet Drugs 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000002110 toxicologic effect Effects 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 208000009421 viral pneumonia Diseases 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/648—Myriapods, e.g. centipedes or millipedes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/65—Amphibians, e.g. toads, frogs, salamanders or newts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/233—Bupleurum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/238—Saposhnikovia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Insects & Arthropods (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Otolaryngology (AREA)
- Communicable Diseases (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及医药技术领域，具体涉及季德胜蛇药物组合物在制备治疗新冠病毒感染所致头痛、咽痛的药物中的用途。本发明提供的季德胜蛇药物组合物或其制剂在制备预防、缓解、辅助治疗或治疗新冠病毒感染或新冠病毒感染所致疾病的药物中的用途。本发明研究发现季德胜蛇药物组合物，可以预防、缓解、辅助治疗或治疗新冠病毒感染或新冠病毒感染所致疾病，尤其是新冠病毒感染所致疾病包括咽痛、头痛、发热、恶寒、乏力、身体酸痛或肺炎。
Description
技术领域
本发明涉及医药技术领域，具体涉及季德胜蛇药物组合物或其制剂在制备预防、缓解、辅助治疗或治疗新冠病毒感染或新冠病毒感染所致头痛、咽痛的药物中的用途。
背景技术
开发有效预防和/或治疗新型冠状病毒感染或新冠病毒感染所致疾病的药物产品成为迫切需要解决的问题。
发明内容
因此，本发明要解决的技术问题在于提供季德胜蛇药物组合物或其制剂在制备预防、缓解、辅助治疗或治疗新冠病毒感染或新冠病毒感染所致头痛、咽痛的药物中的用途。
为此，本发明提供了如下的技术方案：
季德胜蛇药物组合物或其制剂在制备预防、缓解、辅助治疗或治疗新冠病毒感染或新冠病毒感染所致疾病的药物中的用途。
可选的，还包括联合正柴胡饮药物组合物或其制剂在制备预防、缓解、辅助治疗或治疗新冠病毒感染或新冠病毒感染所致疾病的药物中的用途；所述正柴胡饮药物组合物的原料药包括柴胡、陈皮、防风、甘草、赤芍和生姜。
可选的，所述新冠病毒感染所致疾病包括咽痛、头痛、发热、乏力、身体酸痛、恶寒或肺炎。
可选的，所述制剂为以季德胜蛇药物组合物为活性组分。
可选的，所述制剂还包括制剂允许的赋形剂或载体。
可选的，所述制剂的形式包括液体制剂或固体制剂。
可选的，所述制剂包括注射剂、片剂、胶囊剂、口服液体剂型、颗粒剂、丸剂或膏剂。
可选的，所述片剂包括普通压制片、包衣片、糖衣片、薄膜衣片、肠溶衣片、泡腾片、咀嚼片、多层片、分散片、舌下片、口含片、溶液片或缓释片；或
所述胶囊剂包括硬胶囊剂、软胶囊剂或肠溶胶囊
本发明技术方案，具有如下优点
1.本发明提供的季德胜蛇药物组合物或其制剂在制备预防、缓解、辅助治疗或治疗新冠病毒感染或新冠病毒感染所致疾病的药物中的用途。本发明研究发现季德胜蛇药物组合物除主治传统的毒蛇、毒虫咬伤外，还具有清热解毒、消肿镇痛之功效，临床实践表明，其还具有消炎、杀菌、祛肿、化腐生肌、改善微循环、调节机体免疫力等作用，对新冠病毒感染患者疗效独特卓著，因此，季德胜蛇药物组合物可以预防、缓解、辅助治疗或治疗新冠病毒感染或新冠病毒感染所致疾病，尤其是新冠病毒感染所致疾病包括咽痛、头痛、发热、乏力、身体酸痛、恶寒或肺炎。
进一步的，本发明还发现正柴胡饮颗粒可以发散风寒，解热止痛，用于外感风寒所致的发热恶寒、无汗、头痛、鼻塞、喷嚏、咽痒咳嗽、四肢酸痛。流感初起、轻度上呼吸道感染见上述证候者，正柴胡饮颗粒的药理毒理试验结果表明：该药具有解热消炎、镇静、镇痛、抗病毒、抑制流感病毒、防治病毒性肺炎、提高人体免疫力等作用，将季德胜蛇药物组合物或其制剂联合正柴胡饮药物组合物或其制剂可以预防、缓解、辅助治疗或治疗新冠病毒感染或新冠病毒感染所致疾病，尤其是新冠病毒感染所致疾病包括咽痛、头痛、发热、乏力、身体酸痛、恶寒或肺炎。
具体实施方式
提供下述实施例是为了更好地进一步理解本发明，并不局限于所述最佳实施方式，不对本发明的内容和保护范围构成限制，任何人在本发明的启示下或是将本发明与其他现有技术的特征进行组合而得出的任何与本发明相同或相近似的产品，均落在本发明的保护范围之内。
实施例中未注明具体实验步骤或条件者，按照本领域内的文献所描述的常规实验步骤的操作或条件即可进行。所用试剂或仪器未注明生产厂商者，均为可以通过市购获得的常规试剂产品。
下述实验例中季德胜蛇药片，由精华制药集团股份有限公司提供。
正柴胡饮颗粒，由精华制药集团股份有限公司提供。
实验例
病例1：刘某某，男，9岁。症状：发烧39.3℃，头痛，恶寒，精神不振。抗原检查：新冠阳性。治疗：每次口服季德胜蛇药片8片，外加两包正柴胡饮颗粒冲服，一天2次，一日后体温恢复正常，精神状态良好，6天后转阴。
病例2:刘某，男，45岁。症状：发烧38.6℃，乏力，浑身酸痛，咽痛。抗原检查：新冠阳性。治疗：每次口服季德胜蛇药片8片，一天2次，一日后体温恢复正常，精神状态尚可，咽痛，痰为黄绿色，加服金荞麦胶囊，7天后转阴。
显然，上述实施例仅仅是为清楚地说明所作的举例，而并非对实施方式的限定。对于所属领域的普通技术人员来说，在上述说明的基础上还可以做出其它不同形式的变化或变动。这里无需也无法对所有的实施方式予以穷举。而由此所引伸出的显而易见的变化或变动仍处于本发明创造的保护范围之中。
Claims (8)
1.季德胜蛇药物组合物或其制剂在制备预防、缓解、辅助治疗或治疗新冠病毒感染或新冠病毒感染所致疾病的药物中的用途。
2.根据权利要求1所述的用途，其特征在于，还包括联合正柴胡饮药物组合物或其制剂在制备预防、缓解、辅助治疗或治疗新冠病毒感染或新冠病毒感染所致疾病的药物中的用途；所述正柴胡饮药物组合物的原料药包括柴胡、陈皮、防风、甘草、赤芍和生姜。
3.根据权利要求1或2所述的用途，其特征在于，所述新冠病毒感染所致疾病包括咽痛、头痛、发热、乏力、身体酸痛、恶寒或肺炎。
4.根据权利要求1-3任一项所述的用途，其特征在于，所述制剂为以季德胜蛇药物组合物为活性组分和/或正柴胡饮药物组合物为活性组分。
5.根据权利要求1-4任一项所述的用途，其特征在于，所述制剂还包括制剂允许的赋形剂或载体。
6.根据权利要求1-5任一项所述的用途，其特征在于，所述制剂的形式包括液体制剂或固体制剂。
7.根据权利要求1-6任一项所述的用途，其特征在于，所述制剂包括注射剂、片剂、胶囊剂、口服液体剂型、颗粒剂、丸剂或膏剂。
8.根据权利要求7所述的用途，其特征在于，所述片剂包括普通压制片、包衣片、糖衣片、薄膜衣片、肠溶衣片、泡腾片、咀嚼片、多层片、分散片、舌下片、口含片、溶液片或缓释片；或
所述胶囊剂包括硬胶囊剂、软胶囊剂或肠溶胶囊。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202310091833.2A CN117257885A (zh) | 2023-02-09 | 2023-02-09 | 季德胜蛇药物组合物在制备治疗新冠病毒感染所致头痛、咽痛的药物中的用途 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202310091833.2A CN117257885A (zh) | 2023-02-09 | 2023-02-09 | 季德胜蛇药物组合物在制备治疗新冠病毒感染所致头痛、咽痛的药物中的用途 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN117257885A true CN117257885A (zh) | 2023-12-22 |
Family
ID=89220263
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202310091833.2A Pending CN117257885A (zh) | 2023-02-09 | 2023-02-09 | 季德胜蛇药物组合物在制备治疗新冠病毒感染所致头痛、咽痛的药物中的用途 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN117257885A (zh) |
-
2023
- 2023-02-09 CN CN202310091833.2A patent/CN117257885A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2450047B1 (en) | Pharmaceutical composition containing ephedrae for treating bronchitis and preparation method therefor | |
| AU2016276145B2 (en) | Formulations for the treatment of disorders of the mouth, throat and respiratory tract | |
| US9675582B2 (en) | Alternative ACT with natural botanical active GRAS ingredients for treatment and prevention of the Zika virus | |
| AU2010310406B2 (en) | Herbal composition comprising ginger and goldenrod for the treatment of cold and flu | |
| US20060222722A1 (en) | Sublingual methods of treatment to alleviate or prevent arthritis | |
| US20060172021A1 (en) | Herbal compositions for the prevention or treatment of symptoms of stress and infection | |
| CN117257885A (zh) | 季德胜蛇药物组合物在制备治疗新冠病毒感染所致头痛、咽痛的药物中的用途 | |
| CN113577187B (zh) | 一种治疗流行性感冒的中药组合物、中药提取物及其制备方法和应用 | |
| WO2023036250A1 (zh) | 用于治疗前列腺炎或前列腺增生的药物 | |
| WO2007059649A1 (fr) | Preparation pharmaceutique chinoise traitant les infections des voies respiratoires et son procede d'elaboration | |
| WO2020187019A1 (zh) | 润肠通便的中药组合物、其制备方法及应用 | |
| WO2019128511A1 (zh) | 片仔癀及其制剂在制备治疗带状疱疹后遗神经痛的药物中的用途 | |
| CN110101751A (zh) | 一种退热解毒口服制剂及其制备方法 | |
| CN115282243B (zh) | 一种治疗小儿急性支气管炎的中药组合物及其制备方法 | |
| WO2022253267A1 (zh) | 一种治疗儿童感冒的中药组合物 | |
| CN1331485C (zh) | 一种感冒药 | |
| WO2012075646A1 (zh) | 治疗甲型流感病毒亚型感染的中药组合物及其制备方法 | |
| CN106491692A (zh) | 一种感冒药 | |
| Henson | Herbal Combination Imupret® Reduces Symptom Severity and Duration of Acute Non-bacterial Tonsillitis in Children. | |
| Okonogi et al. | Efficacy of Andrographis paniculata spray in acute pharyngitis: A randomized controlled trial | |
| CN116785352A (zh) | 一种中药组合物在制备抗新冠病毒omicron变异株药物中的应用 | |
| CN115120666A (zh) | 一种防治腮腺炎的中药组合物 | |
| CN117224642A (zh) | 一种用于治疗病毒感染引起的发热的退热中药组合物及其制备方法与应用 | |
| CN111617225A (zh) | 一种治疗咳嗽类疾病的中药制剂及其制备方法 | |
| CN110893209A (zh) | 用于扁桃体复原的药物及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |